CPHI Podcast Series: The importance of novel excipients for innovative drug development

The latest episode in the CPHI Podcast Series dives into the world of novel excipients and explores their importance for innovative drug development. 

According to the International Pharmaceutical Excipients Council (IPEC), drugs that have yet to be developed may need more excipients than are currently available to us, and many new treatments are unlikely to succeed without novel excipients.

In short – innovation in drug development requires innovation in excipient manufacturing. 

However, the lack of an independent regulatory pathway for novel excipients has historically created barriers to their use and discouraged innovation in the excipients space. In this episode Nigel Langley, Chair of IPEC – Americas and Global Technology Director at BASF Corporation, joins us to discuss developments in the novel excipients arena, as well as the pilot review program launched by the FDA last year.

The cutting edge of drug development at CPHI Barcelona

There's a world of innovation going on in the pharma industry. New ways of working and new ways of driving business. At CPHI Barcelona, you can meet everyone from big hitters to start-up disruptors and learn about the steps they're taking into the future.

Your CPHI Barcelona pass gives you access to all conference sessions, including Formulating the Future, as well as the chance to connect in-person with the global pharma supply chain from 24-26 October, at Fira Barcelona Gran Via. Browse the agenda and secure your pass today!

Learn more